Sagtec Global Limited and Kinetic Seas Inc. Finalize Landmark Partnership to Accelerate AI Co-Development Across Malaysia, Indonesia, Singapore, and the Philippines
Globenewswire· 2025-11-04 21:30
KUALA LUMPUR, Malaysia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (Nasdaq: SAGT) today announced the execution of a landmark addendum to a previously executed licensing agreement dated, significantly expanding its strategic partnership with Kinetic Seas Incorporated (OTCQB:KSEZ) and establishing Kinetic Seas as Sagtec’s exclusive AI development and technology partner for Malaysia, Indonesia, Singapore, and the Philippines. This agreement transforms a training-focused collaboration into a compr ...
Critical Metal Corp Obtains Crucial Environmental Approvals for the Tanbreez Project
Globenewswire· 2025-11-04 21:30
项目进展 - Critical Metals Corp宣布其Tanbreez项目的地球化学测试工作报告已获得批准[1] - 公司于2025年9月29日通过其格陵兰公司Tanbreez Mining Greenland A/S提交了Tanbreez项目山体场址的地球化学测试报告、对比报告以及矿山和关闭计划[2] - 矿物资源活动环境局已通知公司,基于对提交报告的审查,确定所需的地球化学测试工作已完成[2] - 报告由丹麦工程公司NIRAS A/S起草,该公司是全球领先的多学科工程和环境咨询公司[3] - 公司CEO兼执行董事长Tony Sage表示,测试报告的快速批准是公司启动Tanbreez采矿过程的关键里程碑[4] 公司战略与资产组合 - Critical Metals Corp是一家领先的矿业开发公司,专注于关键金属和矿物,为美国、欧洲及其西方世界伙伴生产电气化和下一代技术所必需的战略产品[5] - 公司的旗舰项目Tanbreez是全球最大的稀土矿床之一,位于南格陵兰,该地区拥有全年直达的深水峡湾航运通道,可直接进入北大西洋[5] - 另一关键资产是位于奥地利维也纳以南270公里的Wolfsberg锂项目,该项目是欧洲首个完全获许可的矿山,战略位置优越,可利用现有的公路和铁路基础设施,预计将成为支持欧洲市场的下一个主要锂产品生产商[6] - Wolfsberg项目已与承购和下游合作伙伴建立良好关系,有望在不断扩大的地缘战略关键金属组合中成为独特且有价值的资产[6] - 凭借该战略资产组合,公司定位于成为西方世界国防应用、清洁能源转型和下一代技术所必需的关键矿物的可靠和可持续供应商[7] 后续步骤 - Tanbreez项目待获得的剩余批准包括矿山和关闭计划剩余部分的批准,以及特定活动计划的批准[9]
Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
Globenewswire· 2025-11-04 21:30
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Monday, November 10, 2025, to review the company’s third quarter 2025 financial results and provide business updates. The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave ...
Ocean Power Technologies Recognized as Certified AUVSI Trusted UMS Operator Training Provider
Globenewswire· 2025-11-04 21:30
公司认证与行业地位 - 公司获得国际无人系统协会认证,成为可信无人海事系统操作员培训提供商,标志着无人水面艇操作专业化的重要里程碑 [1] - 公司成为全国首个行业主导的无人海事系统框架下,有资格提供AUVSI认证培训的少数组织之一 [2] - 通过此认证,公司加入了推动无人系统行业安全、专业化和创新的可信提供商网络 [6] 培训业务详情 - 培训服务面向政府、国防、商业和学术领域的专业人士,旨在获得无人水面艇操作认证 [3] - 培训将使用公司成熟的WAM-V®平台进行,该平台以适应性、稳定性和多任务 versatility 著称 [3] - 此项培训是创收业务,将在公司位于太平洋和大西洋的地点以及客户现场提供 [3] 战略意义与市场影响 - 认证强化了公司对推进安全、有效和专业无人操作的承诺,并支持其经常性收入努力 [4][6] - 培训计划旨在确保操作员能够以最高的安全和能力标准完成任务目标 [4] - 该认证扩大了符合新兴监管、操作和安全标准的操作员培训渠道,支持无人海事行业的持续增长 [5] 公司业务概览 - 公司为国防和安全、石油和天然气、科学与研究以及海上风电市场提供智能海事解决方案和服务 [8] - 公司产品组合包括Merrows™ AI集成系统、PowerBuoy®平台以及WAM-V®自主水面艇和海洋机器人服务 [8]
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th
Globenewswire· 2025-11-04 21:30
MOUNTAIN VIEW, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced that Shaun Bagai, Chief Executive Officer, will be participating at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum, to be held on November 20, 2025. Mr. Bagai will share an update on RenovoRx’s c ...
CVRx to Present at the Jefferies Global Healthcare Conference in London
Globenewswire· 2025-11-04 21:30
MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at the Jefferies Global Healthcare Conference in London on Tuesday, Nov. 18, 2025. The Company is scheduled to present at 8:00 a.m. (GMT) / 4:00 a.m. (ET) the same day via webcast. A live audio we ...
Reliance Global Group Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
Globenewswire· 2025-11-04 21:30
Lakewood, NJ, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ: RELI) (“Reliance” or the “Company”), announced today that it will host a conference call Thursday, November 6, 2025, at 4:30 PM Eastern Time to discuss financial results for the third quarter 2025 and provide a business update. The conference call will be available via telephone by dialing toll-free +1 800-715-9871 for U.S. callers or +1 646-307-1963 for international callers and entering access code Reliance Global Group I ...
VisionWave Holdings Strengthens Global Advisory Board with Appointment of Admiral (Ret.) Eli Marum and U.S. Ambassador (Ret.) Ned L. Siegel
Globenewswire· 2025-11-04 21:30
公司战略与人事任命 - 公司任命以色列海军前总司令Eli Marum上将和美国前驻巴哈马大使Ned L Siegel加入其顾问委员会[1] - 此次任命旨在将公司定位为下一代技术与盟国国家安全创新之间的桥梁[2] - 新任顾问将帮助公司扩大全球合作伙伴关系和战略计划[9] 新任顾问背景与专长 - Eli Marum上将在以色列海军担任过几乎所有高级指挥职务,包括海军作战部长和总司令,并领导了2006年黎巴嫩战争后以色列海军的全面现代化和战略重建[3][4] - Ned L Siegel大使拥有超过四十年的外交、商业和政策经验,曾担任美国驻巴哈马大使,并在私营部门担任专注于房地产、能源、基础设施和安全技术的国际商业咨询公司总裁[6][7] - 两位新任顾问与公司现有顾问、英国前议员及国家安全政策制定者Ben Everitt共同体现了公司对强有力治理、国际合作和使命驱动创新的持续承诺[10] 公司业务与技术定位 - 公司是一家国防技术和人工智能驱动的传感公司,开发和商业化集成基于人工智能的传感、雷达和自主系统的下一代国防技术,应用于空中、陆地和海上领域[11] - 公司的使命是为全球政府、国防和商业客户增强态势感知、安全性和决策能力[11] - 公司强调其不仅开发技术,更在建立重新定义国防创新如何触及现实世界的联系[9]
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
Globenewswire· 2025-11-04 21:30
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report financial results for its third quarter 2025, for the period ended September 30, 2025, on Tuesday, November 11, 2025, before market ...
Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights
Globenewswire· 2025-11-04 21:30
— Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7% — Third quarter pulse recurring revenue of $8.3M, +55% year-over-year growth — First nine months revenue of $58.7M, +42% year-over-year growth; IFRS gross margin of 75.1% — First nine months IFRS and non-IFRS net income of $1.4M and $3.2M, respectively, versus a net loss of $3.8M and $2.1M, respectively, in the same year ago period — Approximately 667,00 pulse treatments administered since commer ...